Marcio Ferreira de Souza

Statistics

Publications

Citations

537

H-Index

Active since

2017

Affiliations

PTC Therapeutics (United States)(Current)

University of California, Davis

University of California, Los Angeles

Marcio Ferreira de Souza is an author at PTC Therapeutics (United States) specializing in duchenne muscular dystrophy pharmacotherapy, muscular dystrophy, and medicine.

ORCID

Publications per year

2017–2020

Publications

Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Craig M. McDonald, Craig Campbell, Ricardo Erazo Torricelli et al. · The Lancet · 2017 · 455 citations · Full text

Medicine, Molecular Medicine, Neurology +9

Deflazacort versus prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post HOC analysis from the ACT DMD trial

Perry B. Shieh, Joseph McIntosh, Fengbin Jin et al. · Muscle & Nerve · 2018 · 59 citations · Full text

Medicine, Pharmacotherapy, Rehabilitation Medicine +17

Assessment of Treatment Effect With Multiple Outcomes in 2 Clinical Trials of Patients With Duchenne Muscular Dystrophy

Daniel Li, Craig M. McDonald, Gary Elfring et al. · JAMA Network Open · 2020 · 13 citations · Full text

Medicine, Translational Sciences, Outcomes Research +14

Ataluren Pharmacokinetics in Healthy Japanese and Caucasian Subjects

Ronald Kong, Oscar L. Laskin, Diksha Kaushik et al. · Clinical Pharmacology in Drug Development · 2019 · 10 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +10

1–4 of 4